-
1
-
-
0034766578
-
The pharmacology of bimatoprost (Lumigan)
-
Woodward DF, Krauss AH, Chen J, Lai RK, Spada CS, Burk RM, Andrews SW, Shi L, Liang Y, Kedzie KM, Chen R, Gil DW, Kharlamb A, Archeampong A, Ling J, Madhu C, Ni J, Rix P, Usansky J, Usansky H, Weber A, Welty D, Yang W, Tang-Liu DD, Garst ME, Brar B, Wheeler LA, Kaplan LJ. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol. 2001;45(Suppl 4):S337-345.
-
(2001)
Surv Ophthalmol
, vol.45
, Issue.4 SUPPL.
-
-
Woodward, D.F.1
Krauss, A.H.2
Chen, J.3
Lai, R.K.4
Spada, C.S.5
Burk, R.M.6
Andrews, S.W.7
Shi, L.8
Liang, Y.9
Kedzie, K.M.10
Chen, R.11
Gil, D.W.12
Kharlamb, A.13
Archeampong, A.14
Ling, J.15
Madhu, C.16
Ni, J.17
Rix, P.18
Usansky, J.19
Usansky, H.20
Weber, A.21
Welty, D.22
Yang, W.23
Tang-Liu, D.D.24
Garst, M.E.25
Brar, B.26
Wheeler, L.A.27
Kaplan, L.J.28
more..
-
2
-
-
0034766992
-
Mechanism of action of bimatoprost (Lumigan)
-
Brubaker RF. Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol. 2001;45(Suppl 4):S347-351.
-
(2001)
Surv Ophthalmol
, vol.45
, Issue.4 SUPPL.
-
-
Brubaker, R.F.1
-
3
-
-
0033428736
-
Latanoprost 0.005% and anterior segment uveitis
-
Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC. Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand. 1999;77(6):668-672.
-
(1999)
Acta Ophthalmol Scand
, vol.77
, Issue.6
, pp. 668-672
-
-
Smith, S.L.1
Pruitt, C.A.2
Sine, C.S.3
Hudgins, A.C.4
Stewart, W.C.5
-
4
-
-
0032914325
-
Latanoprost-induced uveitis
-
Warwar RE, Bullock JD. Latanoprost-induced uveitis. Surv Ophthalmol. 1999;43(5):466-468.
-
(1999)
Surv Ophthalmol
, vol.43
, Issue.5
, pp. 466-468
-
-
Warwar, R.E.1
Bullock, J.D.2
-
5
-
-
0031850376
-
Anterior uveitis associated with
-
Fechtner RD, Khouri AS, Zimmerman TJ, Bullock J, Feldman R, Kulkarni P, Michael AJ, Realini T, Warwar R. Anterior uveitis associated with. Am J Ophthalmol. 1998;126(1):37-41.
-
(1998)
Am J Ophthalmol
, vol.126
, Issue.1
, pp. 37-41
-
-
Fechtner, R.D.1
Khouri, A.S.2
Zimmerman, T.J.3
Bullock, J.4
Feldman, R.5
Kulkarni, P.6
Michael, A.J.7
Realini, T.8
Warwar, R.9
-
6
-
-
0036182839
-
Cystoid macular edema associated with ocular hypotensive lipids
-
Wand M, Gaudio AR. Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol. 2002;133(3):403-405.
-
(2002)
Am J Ophthalmol
, vol.133
, Issue.3
, pp. 403-405
-
-
Wand, M.1
Gaudio, A.R.2
-
8
-
-
0031241723
-
An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems
-
Sharma S, Sharma SC. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems. Indian J Exp Biol. 1997;35(10): 1025-1023.
-
(1997)
Indian J Exp Biol
, vol.35
, Issue.10
, pp. 1025-1023
-
-
Sharma, S.1
Sharma, S.C.2
-
9
-
-
0028906566
-
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
-
Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA. 1995;92(8):3376-3380.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, Issue.8
, pp. 3376-3380
-
-
Facci, L.1
Dal Toso, R.2
Romanello, S.3
Buriani, A.4
Skaper, S.D.5
Leon, A.6
-
10
-
-
0019799332
-
A method for estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
-
(1981)
Clin Pharmacol Ther
, vol.30
, Issue.2
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
Sandor, P.4
Ruiz, I.5
Roberts, E.A.6
Janecek, E.7
Domecq, C.8
Greenblatt, D.J.9
|